Loading Events

« All Events

  • This event has passed.

Lunch & Learn about Lynch Syndrome and Endometrial Cancer

June 6 2023 @ 1:00 PM - 2:00 PM

Lynch Syndrome (LS) is an inherited condition caused by pathogenic variants in DNA genes which result in an increased risk of colorectal, endometrial, and other cancers.

Lynch Syndrome (previously known as hereditary non-polyposis colorectal cancer (HNPCC) increases risk of developing bowel cancer to up to 80%

Approximately 200,000-300,000 people likely to have this inherited condition in the UK. However, it is estimated that only 5% of people with Lynch Syndrome have actually been diagnosed.

We are trying to change that!

Genetic testing can provide a definitive diagnosis for someone with Lynch and open up new screening and treatment options. All patients with colorectal (CRC) [DG27] and endometrial cancer [DG42] should now receive genetic testing according to NICE guidelines.

Come and learn how you can achieve that for your patients.

Register via Eventbrite here 

Our sessions are relevant to anyone who is part of a Cancer MDT.

Leading Lynch & Genomic experts will be leading the sessions including:

  • Kevin Monahan, Consultant Gastroenterologist at St Mark’s Hospital and Co-Chair of the national NHS GMS Lynch Syndrome Oversight Group
  • Adam Shaw, Consultant Geneticist at Guy’s and St Thomas’ and Co-Chair of the national NHS GMS Lynch Syndrome Oversight Group
  • Nick West, Associate Professor of Pathology and Honorary Consultant in Gastrointestinal and Molecular Pathology, Leeds Teaching Hospitals NHS Trust
  • Professor Emma Crosbie, Professor of Gynaecological oncology
  • Laura Monje-Garcia, National lead nurse for the Lynch Syndrome project

If you can’t make this session, we have others available on the following dates:

  • June 13th 1-2pm with colorectal focus
  • September 5th 1-2pm with endometrial focus
  • September 22nd 1-2pm with colorectal focus

See our website or Eventbrite to register for these alternate dates.


Online Webinar
United Kingdom + Google Map
With any Whole Genome Sequencing (WGS) test ordered, a Record of Discussion (RoD) form will also need to be submitted. This document is to record the patient’s consent for genomic testing and their choice on taking part in research. Guidance on the patient choice conversation can be found here
This RoD form will be available for clinicians to download from this webpage. Once completed with the patient, it can be send to the lab with the corresponding test order form and sample.
Tests available to order will be listed in the National Genomic Test Directory. A test order form will soon be made available for clinicians on this webpage to download and complete. This form will include the address of the laboratory that the appropriate sample and completed form needs to be sent to.
Until the new Genomic Laboratory Service goes live, please continue to follow existing test order processes.
Later this year, the online test ordering tool for Whole Genome Sequencing will be integrated into the National Genomics Informatics System (NGIS) and clinicians will be able to search or filter to find a clinical indication, confirm eligibility criteria and start the test request process for their patient.